Quarterly Result25 Mar 2026, 03:01 pm
Samrat Pharmachem Ltd. to Approve Audited Financial Results on May 30, 2026
AI Summary
Samrat Pharmachem Ltd. has announced that its Board of Directors will meet on May 30, 2026, to consider and approve the Audited Standalone Financial Results for the financial year ended March 31, 2026. The meeting will be held at the Corporate Office of the Company in Mumbai. The company will intimate the exchanges about the Audited Financial Results upon the conclusion of the Board Meeting and will announce the same in the Press and on the company’s website as required under the Listing Agreement.
Key Highlights
- Samrat Pharmachem Ltd. to hold a Board Meeting on May 30, 2026
- The meeting will consider and approve the Audited Standalone Financial Results for the financial year ended March 31, 2026
- The meeting will be held at the Corporate Office of the Company in Mumbai
- The company will intimate the exchanges about the Audited Financial Results upon the conclusion of the Board Meeting
- The Audited Financial Results will be announced in the Press and on the company’s website as required under the Listing Agreement
Price Impact
More from SAMRATPH